Likewise, IL-6 and leptin derived from adipocytes could increase the PD-L1/NKG2D ligand level in cancer cells by activating the JAK/STAT3 signaling pathway, thereby decreasing the cytotoxicity of NK cells to tumor cells [82]. Here, IL6 is linked to neoplasm.